Madison Marasco
About Madison Marasco
Madison Marasco is a Postbaccalaureate IRTA/CRTA conducting research at the National Cancer Institute, part of the National Institutes of Health, focusing on a novel DNA methyltransferase inhibitor for myelodysplastic syndrome.
Work at National Institutes of Health
Madison Marasco has been employed at the National Institutes of Health (NIH) since 2019. She holds the position of Postbaccalaureate Intramural Research Training Award (IRTA) and Clinical Research Training Award (CRTA) at the National Cancer Institute. In this role, she conducts research focused on cancer treatment, specifically investigating the efficacy of a novel DNA methyltransferase inhibitor for myelodysplastic syndrome.
Education and Expertise
Madison Marasco completed her undergraduate studies at Clemson University, where she earned a degree in Biological Sciences from 2016 to 2019. Her educational background has provided her with a solid foundation in the biological sciences, which she applies in her current research endeavors at the NIH.
Background
Prior to her current role at the NIH, Madison Marasco gained research experience as an intern at Harvard Medical School. She worked at the Dana-Farber Cancer Institute for three months in 2017 and again for three months in 2018. These internships allowed her to develop skills in cancer research and contribute to ongoing projects in the field.
Research Focus
Madison Marasco's research primarily centers on the efficacy of a novel DNA methyltransferase inhibitor as a treatment for myelodysplastic syndrome. Her work contributes to the broader field of cancer research, where understanding the mechanisms of treatment can lead to improved patient outcomes.
Involvement in Cancer Research
Madison Marasco has been actively involved in cancer research since at least 2019. Her experiences at both the Dana-Farber Cancer Institute and the National Cancer Institute reflect her commitment to advancing knowledge and treatment options in oncology.